Ertapenem Sodium Patent Expiration
Ertapenem Sodium is Used for treating bacterial infectious diseases. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Ertapenem Sodium Patents
Given below is the list of patents protecting Ertapenem Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Invanz |
US5952323 (Pediatric) | Carbapenem antibiotic |
Nov 15, 2017
(Expired) | Msd Sub Merck |
| Invanz | US5952323 | Carbapenem antibiotic |
May 15, 2017
(Expired) | Msd Sub Merck |
| Invanz |
US5478820 (Pediatric) | Antibiotic compounds |
May 21, 2016
(Expired) | Msd Sub Merck |
| Invanz | US5478820 | Antibiotic compounds |
Nov 21, 2015
(Expired) | Msd Sub Merck |
| Invanz |
US5652233 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
| Invanz |
US7342005 (Pediatric) | Antibiotic compounds |
Aug 02, 2013
(Expired) | Msd Sub Merck |
| Invanz | US5652233 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
| Invanz | US7342005 | Antibiotic compounds |
Feb 02, 2013
(Expired) | Msd Sub Merck |
Ertapenem Sodium's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List